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Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic
disease caused by defective prelamin A processing, leading to nu-
clear lamina alterations, severe cardiovascular pathology, and pre-
mature death. Prelamin A alterations also occur in physiological
aging. It remains unknown how defective prelamin A processing
affects the cardiac rhythm. We show age-dependent cardiac repo-
larization abnormalities in HGPS patients that are also present in
the Zmpste24−/− mouse model of HGPS. Challenge of Zmpste24−/−
mice with the β-adrenergic agonist isoproterenol did not trigger
ventricular arrhythmia but caused bradycardia-related premature
ventricular complexes and slow-rate polymorphic ventricular rhythms
during recovery. Patch-clamping in Zmpste24−/− cardiomyocytes
revealed prolonged calcium-transient duration and reduced sarco-
plasmic reticulum calcium loading and release, consistent with
the absence of isoproterenol-induced ventricular arrhythmia.
Zmpste24−/− progeroid mice also developed severe fibrosis-unrelated
bradycardia and PQ interval and QRS complex prolongation. These
conduction defects were accompanied by overt mislocalization of the
gap junction protein connexin43 (Cx43). Remarkably, Cx43 mislocali-
zation was also evident in autopsied left ventricle tissue from HGPS
patients, suggesting intercellular connectivity alterations at late
stages of the disease. The similarities between HGPS patients and
progeroid mice reported here strongly suggest that defective cardiac
repolarization and cardiomyocyte connectivity are important abnor-
malities in the HGPS pathogenesis that increase the risk of arrhythmia
and premature death.
Hutchinson–Gilford progeria syndrome | progerin | prelamin A |
connexin43 | calcium handling
The LMNA gene encodes A-type lamins (lamin A and laminC), key components of the mammalian nuclear envelope with
important structural and regulatory functions that affect signaling,
transcription, and chromatin organization among other processes
(1). Mature lamin A is produced from the precursor prelamin
A through a series of posttranslational modifications, consisting
of sequential farnesylation at the cysteine in the Cysteine-Serine-
Isoleucine-Methionine motif, cleavage of the Serine-Isoleucine-
Methionine residues, carboxymethylation of the newly accessible
cysteine, and a final proteolytic cleavage by the zinc metal-
lopeptidase STE24 (ZMPSTE24, also called FACE-1) (2).
Mutations in the human LMNA gene or defective processing of
prelamin A cause a group of diseases termed laminopathies, includ-
ing the premature aging disorder Hutchinson–Gilford progeria syn-
drome (HGPS), a very rare genetic disorder with an estimated
prevalence of 1 in 21 million people (www.progeriaresearch.org).
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HGPS patients exhibit accelerated atherosclerosis and arterial
stiffness, leading to premature death at an average age of 14.6 y, pre-
dominantly from myocardial infarction, heart failure, or stroke (3,
4). Most HGPS patients carry a noninherited de novo heterozygous
synonymous mutation in the LMNA gene (c.1824C > T: GGC >
GGT; p.G608G), which activates the use of an internal 5′ splicing
site in exon 11 that causes the synthesis of progerin. This unpro-
cessed form of prelamin A lacks 50 amino acids encompassing
the ZMPSTE24 cleavage site and therefore, remains perma-
nently farnesylated (2). ZMPSTE24 mutations have also been
linked to several other human progeroid syndromes (5, 6),
reinforcing the notion that accumulation of progerin or prelamin
A accelerates cellular aging. Moreover, progerin and prelamin A
are both expressed in cells and tissues of normally aging non-
HGPS individuals, suggesting their involvement in physiological
aging (reviewed in refs. 2 and 7).
Genetically modified mice expressing prelamin A or progerin
have enabled the study of mechanisms underlying progeria (8)
and testing of the efficacy of various therapies (9, 10). Here, we
examined cardiac electrical alterations in 15 HGPS patients with
the classical LMNA c.1824C > T mutation, representing ∼5% of
the world population (www.progeriaresearch.org). We then corre-
lated the observed alterations in HGPS patients to the underlying
molecular processes in Zmpste24-null mice; these mice accumulate
farnesylated prelamin A in the nuclear envelope and phenocopy
several other defects observed in HGPS, including cardiovascular
alterations and premature death (average lifespan ∼20 wk vs. >2 y
in WT mice) (9, 11).
Results
Electrocardiographic Alterations in HGPS Patients. SI Appendix,
Tables S1 and S2 show electrocardiographic measurements from
HGPS patient carriers of the LMNA c.1824C > T mutation (n =
15, age range 2–19 y old) and controls (n = 13, age range 4–19 y
old), respectively. A glossary of electrocardiographic parameters
can be found in SI Appendix. As they aged, seven patients
showed overt repolarization abnormalities in at least one elec-
trocardiogram (ECG) that were compatible with coronary artery
disease (ST segment depression/elevation and negative and bi-
phasic T waves) (a representative example is in SI Appendix, Fig.
S1A). One patient showed significant QTc interval prolongation
(537 ms) in the context of ischemia at advanced stages of the
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Fig. 1. Age-related exacerbation of repolarization abnormalities in HGPS patients and Zmpste24−/− mice. (A, Left) Extracted averaged ECG leads II and V5
from human control participants (blue traces) and HGPS patients at initial stage (Initial; light red trace) and advanced stages (Last; dark red trace). (A, Right)
Quantification of mean flattening scores. (B, Left) Representative T-wave abnormalities in Zmpste24−/− mice comparing the first and the last isoproterenol
(ISO) challenge (SI Appendix, SI Materials and Methods). (B, Right) Mean effective flattening scores at baseline, after ISO exposure and during 5-min recovery.
*P < 0.05 vs. control; †P < 0.05 vs. first follow-up. First: 11-wk-old mice; Last: 19-wk-old mice or last week before death.
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disease (18 y of age). These alterations were not observed in
controls (a representative example is in SI Appendix, Fig. S1B).
Repolarization abnormalities in HGPS patients were highly ev-
ident at advanced disease stages. Compared with age-matched
controls, HGPS patients exhibited significant T-wave flattening,
which was exacerbated as disease progressed (Fig. 1A, initial:
initial ECG; last: last ECG during follow-up). All patients and
controls had sinus rhythm and normal PR interval and QRS
complex duration (SI Appendix, Tables S1 and S2). Interestingly,
although all HGPS patients exhibited cardiac rhythm within
physiological values, the heart rate and PR interval tended to be
slower and larger, respectively, in older HGPS patients (6 of 15)
at the end of the follow-up period (26.8 ± 2.3 mo follow-up):
heart rates on first and last ECGs were 114 ± 7 and 101 ± 7 beats
per minute (bpm), respectively, P = 0.36; PRs on first and last
ECGs were 115 ± 2 and 128 ± 11 ms, respectively, P = 0.22.
Time Course of ECG Abnormalities in Progeroid Zmpste24−/− Mice.
We next analyzed the electrocardiographic phenotype of
Zmpste24−/− mice, an established preclinical model of HGPS (9,
11). A glossary of electrocardiographic parameters can be found
in SI Appendix. To study repolarization, we quantified T-wave
flattening by measuring T-wave morphology changes, including
sharpness, by excess kurtosis of the T-wave peak in relation to its
geometrical change from the isoelectric line and the area under
the T wave (SI Appendix, SI Materials and Methods). Similar to
HGPS patients, progeroid mice showed repolarization abnor-
malities manifested as significant T-wave flattening. To deter-
mine the risk of ventricular arrhythmia associated with T-wave
alterations, we used the β-adrenergic agonist isoproterenol, which
can trigger calcium-related alterations in cardiac repolarization.
Weekly isoproterenol challenge, based on its sympathomimetic
effect and ability to induce Ca2+-related alterations in repolari-
zation, further exacerbated the repolarization alterations as
Zmpste24−/− mice aged, although acute isoproterenol did not
cause significant ventricular arrhythmias in Zmpste24−/− or
controls (Fig. 1B). Although both groups responded normally in
the first week of follow-up, older Zmpste24−/− mice developed a
very marked reduction in the heart rate (bradycardia) during
recovery from isoproterenol (Fig. 2A). In addition, compared
with WT controls, Zmpste24−/− mice progressively developed
longer RR intervals as they aged (Fig. 2 B and C). The variability
of the RR interval, measured as the SD, increased linearly as a
function of the average RR interval (SI Appendix, Fig. S2) and
was associated with increased incidence of premature ventricular
complexes (Fig. 2D and SI Appendix, Fig. S3) and a short lifespan.
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Fig. 2. Severe bradycardia in postisoproterenol (post-ISO) administration recovery is associated with an increase in premature ventricular complexes in
Zmpste24−/− mice. First: 11-wk-old mice; Last: 19-wk-old mice or last week before death. (A) β-Adrenergic response [interbeat interval (IBI)] in WT and
Zmpste24−/− mice from the first to the last ISO challenge. 95% CI, 95% confidence interval. (B) RR histograms in WT and Zmpste24−/− mice during ISO time
course challenge. The Insets show correlation plots between consecutive cardiac beats (RRn vs. RRn + 1; n = cardiac beat number within the entire registration
period; color-coded timescale). A significant increase in the percentage of long RR intervals during the last week of follow-up (C) was also associated with a
significant increase in bradycardia-related premature ventricular complexes (D). *P < 0.05; **P < 0.01 (SI Appendix, SI Materials and Methods).
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During both isoproterenol challenge (SI Appendix, Fig. S4) and
recovery (SI Appendix, Fig. S5), Zmpste24−/− mice showed in-
creased prolongation of PQ and QRS intervals. Progeroid
Zmpste24−/− mice also developed age-dependent bradycardia in
the absence of isoproterenol (Fig. 3A). In addition, at 18–20 wk of
age, Zmpste24−/−mice showed significant signs of defective cardiac
conduction compared with age-matched controls manifested as
prolonged PQ interval and QRS complex, without alterations to
the QTc interval (Fig. 3 B–E and SI Appendix, Table S3).
Preserved Cardiac Function in Zmpste24−/− Mice. Transthoracic
echocardiography revealed no abnormalities in left ventricle end
diastolic [left ventricular internal diameter at diastole (LVIDd)]
or left ventricle end systolic [left ventricular internal diameter at
systole (LVIDs)] parameters in progeroid Zmpste24−/− mice
(Fig. 3F). Likewise, Zmpste24−/− mice had normal left ventricle
mass, posterior wall and interventricular septal thickness at di-
astole (SI Appendix, Fig. S6A), and diastolic function but had a
slightly higher left ventricle ejection fraction (EF) and fractional
shortening than controls (Fig. 3F and SI Appendix, Fig. S6A),
although within the normal range. The higher EF in progeriod
mice might be explained by bradycardia, because longer diastolic
intervals may favor such an increase. In fact, together, bradycardia
and smaller body surface area in Zmpste24−/− mice explain the sig-
nificantly lower cardiac output compared with WT controls (SI Ap-
pendix, Fig. S6B). However, cardiac index, which relates the cardiac
output of the left ventricle per minute to body surface area, was not
different between progeroid and WT mice (SI Appendix, Fig. S6B).
Time course studies showed no between-genotype differences in
systolic or diastolic blood pressure (SI Appendix, Fig. S6C).
Ex Vivo Cellular Electrophysiology. We next conducted electro-
physiology studies in cardiac multicellular preparations from
Zmpste24−/− mice to identify potential mechanisms underlying
the arrhythmia risk associated with abnormal repolarization. No
significant between-genotype differences were found in resting
membrane potential, action potential (AP) amplitude, maximum
velocity of depolarization (Vmax), or AP duration in right or left
ventricular samples (SI Appendix, Table S4). Moreover, APs recor-
ded in right and left ventricular preparations were indistinguishable
between genotypes (Fig. 4A). Interestingly, most Zmpste24−/− ven-
tricular preparations exhibited slow spontaneous automatic activity
at ∼3 Hz (Fig. 4B). Also, Zmpste24−/− left ventricle preparations dis-
played afterdepolarizations that led to triggered APs, contrasting
with normal AP in controls (Fig. 4 B and C).
We next analyzed transcription of genes encoding ion channel
proteins involved in the different phases of the AP. Real-time
quantitative PCR (qPCR) analysis in Zmpste24−/− hearts
revealed no significant between-group differences in mRNA
expression of Scn5A (encoding the cardiac sodium channel
NaV1.5; involved in cell depolarization) or Kcna5, Kcnj2, Kcnd3,
and Kcnq1 (encoding the potassium channels Kv1.5, Kir2.1, Kv4.3,
and Kv7.1, respectively; all involved in AP repolarization); in
contrast, Zmpste24−/− hearts showed significant up-regulation of
Kcnh2 (encoding the potassium channel Kv11.1, also known as
human ether-à-go-go related gene (hERG; involved in AP repo-
larization) (SI Appendix, Fig. S7).
Zmpste24−/− Mice Show Defective Sarcoplasmic Reticulum Ca2+
Handling. We next investigated the role of intracellular Ca2+
handling in the observed in vivo afterdepolarizations and trig-
gered APs in multicellular left ventricle Zmpste24−/− prepara-
tions. Unlike WT cardiomyocytes, Zmpste24−/− cardiomyocytes
were unable to maintain stable Ca2+ transients at higher stimu-
lation frequencies, an effect that was more prominent at 5 mM
extracellular Ca2+ (Fig. 5A). To test whether this defect in
Zmpste24−/− cardiomyocytes was caused by unstable calcium
release from the sarcoplasmic reticulum (SR) through the ryano-
dine receptor type 2 (RyR2) channel, we measured the frequency
of spontaneous calcium waves at rest. However, we found no dif-
ferences in the calcium wave frequency at any of the calcium con-
centrations examined (Fig. 5B). In line with these results, Zmpste24
deficiency did not affect the transcript level of RyR2 (Fig. 5C),
which is responsible for calcium release from the SR (12).
These findings suggested possible impairment of L-type
Ca2+ currents (ICa) or Ca
2+ uptake by the SR in Zmpste24−/−
cardiomyocytes as alternative causes for unstable calcium transients.
Compared with WT controls, Zmpste24−/− hearts expressed sig-
nificantly lower transcript and protein levels of SR Ca2+ ATPase,
whereas there was no alteration in transcript levels of STIM1
(stromal interaction molecule component of the store-operated
Ca2+ entry 1) and Orai1 (component of the store-operated Ca2+
entry), essential regulators of Ca2+ release-activated Ca2+
channels (Fig. 5 C and D). We also analyzed the expression of
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calsequestrin 1 (CSQ1) and CSQ2, calcium-binding proteins of
the SR that help this organelle store a very high amount of Ca2+
during relaxation in each contraction–relaxation cycle. Although
CSQ1 and CSQ2 transcript levels were significantly lower in
Zmpste24−/− hearts (Fig. 5C), no between-genotype differences
were observed at the protein level (Fig. 5D). Likewise, peak ICa
did not differ significantly between cardiomyocytes of the two
genotypes (SI Appendix, Fig. S8).
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To determine SR Ca2+ reloading function in ventricular car-
diomyocytes, we loaded the SR by exposing cells to an increasing
number of stimulation pulses and estimated the resulting Ca2+
load from caffeine-elicited inward current traces (Fig. 6A). SR
reloading function was significantly weaker in Zmpste24−/− car-
diomyocytes than in WT cells after 5, 10, and 20 stimulation
pulses (Fig. 6B), and the defective response was still more ap-
parent after ≥30 stimulation pulses (Fig. 6C). Significantly lower
SR Ca2+ loading in Zmpste24−/− cardiomyocytes was also evident
from caffeine-elicited current traces recorded after loading the
SR by depolarizing the membrane potential for 5 s to −40, −30,
−20, or 0 mV (Fig. 6 D and E). In addition, intracellular Ca2+
transients recorded in isolated cardiomyocytes paced at 0.5 Hz
revealed a significantly longer Ca2+-transient duration (at half-
maximal amplitude) in Zmpste24−/− cells (Fig. 6F).
Finally, we measured the SR Ca2+ release-dependent in-
activation of the ICa in response to consecutive stimulation pulses
given after clearance of SR Ca2+ (Fig. 7A) to assess the feedback of
SR calcium release on ICa inactivation. As expected, current traces
recorded in WT cardiomyocytes showed a faster rate of ICa in-
activation as the number of pulses used for SR reload increased
from 1 (p1) to 30 (p30) (Fig. 7B). In contrast, the effect of SR
loading on the ICa inactivation rate in Zmpste24
−/− cardiomyocytes
was very modest (Fig. 7B). Accordingly, the time constant for ICa
inactivation decreased progressively with increasing pulse number
in WT but not Zmpste24−/− cardiomyocytes (Fig. 7C). Moreover,
the amplitude of the intracellular Ca2+ transient induced by re-
peated stimulation at 0.5 Hz was significantly lower in Zmpste24−/−
cardiomyocytes (Fig. 7D). Together, these findings indicate that SR
Ca2+ uptake and release are blunted in Zmpste24− /− car-
diomyocytes, which also explains the failure of acute isoproterenol
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treatment to induce ventricular arrhythmia, despite abnormal
repolarization.
Abnormal Connexin43 Localization in the Hearts of Zmpste24−/− Mice
and HGPS Patients. To further investigate conduction alterations
in progeria, we performed immunohistopathological studies in
heart tissue. Cardiomyocyte size was estimated by quantifying
their cross-sectional area in heart sections as well as the mem-
brane capacitance, which is linearly proportional to the plasma
membrane area and cell size. Because Zmpste24−/− mice are
smaller than age-matched controls (9, 11), we normalized results
by tibia length. Normalized cross-sectional area and membrane
capacitance were similar in cardiomyocytes of both genotypes (SI
Appendix, Fig. S9). We also performed Mallory’s trichrome
staining, which revealed normal chambers, ventricular walls, and
myocardial fiber arrangement in Zmpste24−/− hearts (SI Appen-
dix, Fig. S10 A and B). Moreover, Mallory’s trichrome staining
did not reveal increased fibrosis in the ventricular interstitium
(SI Appendix, Fig. S10B) or key structures involved in cardiac
conduction, such as the atrioventricular node and the main His
bundles (SI Appendix, Fig. S10C), which might have explained
conduction abnormalities in Zmpste24−/− mice. However, con-
sistent with previous studies in HGPS patients (13), Zmpste24−/−
mice showed extensive fibrosis in the tunica media of the major
coronary arteries (SI Appendix, Fig. S11A) and discontinuous
and weak expression of smooth muscle actin within the medial
arterial layer (SI Appendix, Fig. S11B).
Another possible explanation for the observed cardiac con-
duction anomalies is altered expression of intercalated disk
proteins that play a key role in intercellular connectivity, such as
the gap junction protein connexin43 (Cx43) and plakoglobin,
as well as cytoskeletal desmosome-interacting proteins, such as
desmin, a class III intermediate filament connected to A-type
lamins through Nesprin/Sun protein complexes. Western blot
analysis in progeroid hearts revealed a significant approximately
twofold increase in Cx43 expression without changes in plako-
globin or desmin (SI Appendix, Fig. S12). Remarkably, com-
pared with WT controls, Zmpste24−/− cardiomyocytes exhibited
marked mislocalization of Cx43 to the cytoplasm and the lateral
long axis as revealed by double immunofluorescence to simul-
taneously detect Cx43 and N-Cadherin (Fig. 8A). Quantification
of digital images revealed less Cx43/N-Cadherin colocalization in
the hearts of progeroid mice than in WT controls (Fig. 8E).
Profound Cx43 mislocalization was also revealed by immu-
nostaining of left ventricle specimens obtained from two HGPS
patients at autopsy. In these patients, Cx43 was abundantly as-
sociated with the perinuclear rim (Fig. 8 B–D), which is its
trafficking origin for subsequent targeting to the intercalated
disks (14) (Discussion). Quantification of digital images con-
firmed a low percentage of Cx43/N-Cadherin colocalization in
HGPS hearts (Fig. 8E). Defective cardiomyocyte connectivity
associated to Cx43 mislocalization may contribute to cardiac
conduction defects in progeria (Discussion).
Discussion
HGPS is a devastating genetic disease resulting from abnormal
processing of prelamin A, which is characterized by premature
cardiovascular disease and death at an average age of 14.6 y old
(4). Here, we provide a comprehensive analysis of electrocar-
diographic abnormalities and underlying molecular changes at
different stages of HGPS. Our findings may have implications for
the risk of premature death in HGPS patients and potentially,
normal aging, because defective prelamin A processing has also
been revealed in cells and tissues of normally aging non-HGPS
individuals (reviewed in refs. 2 and 7). A previous study identi-
fied repolarization abnormalities in 3 of 15 HGPS patients with
the “classical” LMNA c.1824C > T mutation (3). Here, we confirm
and extend these findings through a rigorous examination of a new
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cohort of 15 HGPS patients carrying the same mutation. One-half
of the patients showed overt repolarization abnormalities in at least
one ECG compatible with coronary artery disease (ST depression/
elevation and negative and biphasic T waves). Repolarization ab-
normalities in HGPS patients were strongly evident at advanced
disease stages. We also detected prominent mislocalization of Cx43
in left ventricle specimens obtained at autopsy from diseased
HGPS patients; Cx43 mislocalization was also observed in the
hearts of progeroid Zmpste24−/− mice and is indicative of defective
cardiac conduction in progeria (see below).
Animal models resembling the clinical phenotype of HGPS
patients are central to understanding the underlying mechanisms
of the disease and developing novel therapies. Our analysis
of the well-established Zmpste24−/− mouse model of progeria
caused by prelamin A accumulation (9, 11) revealed the pro-
gressive development of cardiac rhythm alterations that can lead
to premature death. Zmpste24−/− hearts and cardiomyocytes showed
the following specific alterations: (i) T-wave repolarization ab-
normalities, which were also present in one-half of HGPS pa-
tients; (ii) prolonged PQ interval and wide QRS complex;
(iii) development of bradycardia-related premature ventricular
complexes and slow-rate polymorphic ventricular rhythms at late
disease stages in the absence of ventricular arrhythmias during
isoproterenol challenge; (iv) automatic spontaneous ventricular
activity and afterdepolarizations ex vivo, which were associated
with significantly slowed ICa inactivation and reduced amplitude
of the intracellular Ca2+ transient; and (v) mislocalization of
Cx43 in the heart.
Notably, some characteristics of the progeroid Zmpste24−/−
mouse heart are also present in HGPS patients and frequently
observed in normal aging; these characteristics include extensive
fibrosis and loss of smooth muscle cells in coronary arteries,
defective calcium homeostasis, progressive development of re-
polarization defects, and Cx43 mislocalization (15–17). Overt
repolarization abnormalities in ST T waves and T-wave flatten-
ing in mice did not increase the risk of isoproterenol-triggered
ventricular arrhythmia. However, T-wave alterations are well-
known to increase the risk of lethal ventricular arrhythmias
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during ischemia (18), which might contribute to premature
death in HGPS patients from myocardial infarction, one of
the main causes of death in this population. T-wave abnor-
malities might be explained at least in part by an altered re-
polarization pattern brought about by two opposing ion channel
changes observed in the hearts of Zmpste24−/− mice: on the one
hand, the significant up-regulation of Kcnh2, which encodes
the hERG channel responsible for IKr, would help terminate the
AP plateau and shorten repolarization (19), and on the other
hand, the observed slow ICa inactivation would tend to prolong
the plateau and delay repolarization (20). Importantly, an ab-
normally long QTc interval was observed in only 1 of 51 ECGs
from 15 HGPS patients and occurred in the context of ischemia
and significant repolarization anomalies. Consistently, we ob-
served no significant QTc prolongation in Zmpste24−/− mice, in
agreement with the normal AP duration observed in Zmpste24−/−
ventricular cardiomyocytes and the majority of ECG traces from
HGPS patients. Although we documented significant QRS com-
plex widening in progeroid mice, it is important to note that the
high-amplitude QRS complex in the mouse ECG represents not
only the spread of depolarization across the ventricle but also, the
early phase of repolarization (21). We, therefore, carefully ex-
amined QRS complex and QT duration (QT90) (Fig. 3 B–E) to
detect any significant increases in both parameters. However,
mouse and human QT intervals must be compared with caution.
The occurrence of bradycardia-related premature ventricular
complexes in Zmpste24−/− mice during recovery after isoproter-
enol shows a significant suppression of normal pacemaker ac-
tivity, with emergence of ventricular ectopic escape discharges.
Isoproterenol-induced heart rate increase in vivo is associated
with increases in intracellular Na+ and Ca2+ concentration (22);
these changes, in the presence of the postisoproterenol-induced
bradycardia, likely contributed to the escape discharges and
premature ventricular complexes arising from the Purkinje sys-
tem (SI Appendix, Fig. S3). Our ex vivo experiments with mul-
ticellular ventricular preparations showed afterdepolarizations
during spontaneous ventricular activity at ∼3 Hz, which is similar
to the cycle length after isoproterenol treatment in vivo. Al-
though we were unable to establish the exact origin of these
ventricular afterdepolarizations, the in vivo data support involve-
ment of the Purkinje system, consistent with slow idioventricular
discharges (cycle length = 266.38) (SI Appendix, Fig. S3) arising
from varying Purkinje locations.
Connexins are the pore-forming subunits of gap junctions and
essential for proper intercellular electrical coupling between
cardiomyocytes and AP spread during each cardiac cycle (23,
24). Cx43 is the major connexin expressed in the ventricles. Its
abnormal expression, typically involving down-regulation and
heterogeneous redistribution to the lateral cardiomyocyte mem-
brane, is associated with different forms of chronic heart disease
(hypertrophic, dilated, and ischemic cardiomyopathy) and even
aging (24–26). Defective Cx43 expression results in electrical de-
fects in the myocardium and contributes to arrhythmogenesis.
Therefore, Cx43 mislocalization in the heart may explain, at least
partly, the prolongation of PQ interval and QRS complex in
Zmpste24−/− mice. Interestingly, reduced gap junction coupling
accompanied by Cx43 lateralization has been linked to reduced
functional expression of the alpha subunit (NaV1.5) of the cardiac
sodium channel at the intercalated disk (27), and the reduced
sodium current is likely to have contributed to the significantly
impaired atrioventricular and intraventricular conduction in
Zmpste24−/− mice. Previous computer simulations (28) suggest
that, even in the presence of Cx43 mislocalization and low NaV1.5
expression, a normal peak ICa with slow inactivation and reduced
Ca2+ transients could maintain relatively safe conduction in the
ventricles of Zmpste24−/− mice, albeit at a reduced velocity.
However, a high intracellular Ca2+ concentration would have
compromised propagation safety and caused earlier block as ob-
served for reduced intercellular coupling (28). Because the in-
tercalated disk is regarded as a functional unit, with gap junction
formation requiring the presence of neighboring mechanical
junctions (29), we tested the expression of desmin and plakophi-
lin-2. However, our Western blot analysis in Zmpste24−/− hearts
revealed no alterations in the expression of these proteins.
Consistent with the findings in Zmpste24−/− mice, immuno-
fluorescence studies in left ventricle specimens from deceased
HGPS patients revealed abnormal cellular distribution of Cx43
to a predominantly perinuclear localization. Because Cx43 is
packaged into vesicles at the perinuclear trans-Golgi network
and then transported to the intercalated disk (14), our findings
suggest that abnormal prelamin A processing causes defective
Cx43 targeting to its distinctive microdomain at the gap junctions.
Additional LMNAmutations might also cause cardiomyopathy by
altering connexin expression and/or cellular localization. For ex-
ample, transgenic mice expressing the lamin A N195K mutant,
which causes dilated cardiomyopathy with conduction system
disease in humans, die at an early age because of arrhythmia, and
such a phenotype correlates with cardiac Cx43 and Cx40 mis-
expression and/or mislocalization (30). Future studies are warranted
to elucidate the mechanism causing defective Cx43 microdomain
targeting to gap junctions and their contribution to abnormal cardiac
conduction in progeria.
Some of the nuclear envelope alterations in the heart associ-
ated with prelamin A or progerin expression also occur during
normal aging (15–17), suggesting that shared mechanisms might
cause cardiac alterations in HGPS patients and the geriatric
population. Consistent with this idea, prelamin A and progerin
are both produced in the cells of normally aging individuals, thus
raising the possibility that altered lamin A processing contributes
to normal aging and associated cardiovascular disease (reviewed
in refs. 2 and 7). Much like in normal human aging, progeroid
Zmpste24−/− mice develop coronary fibrosis, bradycardia, and
severe conduction abnormalities. Cardiac conduction abnormal-
ities also arise during aging in WT mice and are associated with
an increased incidence of arrhythmias (31). However, Ca2+
transients differ between Zmpste24−/− mice and normally aging
WT mice (32), with Zmpste24−/− cardiomyocytes being unable to
maintain stable Ca2+ transients at 4 Hz. Ventricular car-
diomyocytes from aged WT mice also have a significantly higher
incidence of spontaneous Ca2+ sparks than cells from young an-
imals; however, we did not observe a similar difference between
progeroid mice and age-matched controls. Zmpste24−/− mice
show weakened ICa inactivation and defective SR Ca
2+ uptake
and release, features also observed in aging human atrial myo-
cytes (15). In line with these findings, Ca2+ transient amplitudes
are reduced in progeroid mice (Fig. 6), aged WT mice (32), and
aged human atrial cardiomyocytes (15).
The progressively developing bradycardia and deteriorating
cardiac conduction in progeriod mice also resemble clinical
rhythm abnormalities observed in the elderly (16, 17). Although
the most common age-related cardiac conduction abnormality in
humans is degenerative fibrosis (33), Zmpste24−/− mice did not
show abnormal fibrosis in the ventricular interstitium or the
major conduction structures. However, in line with observations
in HGPS patients (13), the coronary arteries of Zmpste24−/−
mice showed extensive fibrosis and reduced accumulation of
smooth muscle cells, potential causes of vascular stiffening, re-
duced coronary flow, and abnormal impulse generation in the
sinoatrial node and conduction in the atria and ventricles. The
latter may have also contributed to T-wave alterations, especially
during isoproterenol challenge, as well as progressive develop-
ment of bradycardia in progeroid Zmpste24−/− mice. In fact,
human patients with coronary artery disease show a high prev-
alence of conduction abnormalities, such as atrioventricular or
sinoatrial block (34).
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We provide a comprehensive characterization of cardiac ab-
normalities in HGPS patients and progeroid Zmpste24−/− mice,
identifying a number of cellular and molecular alterations in both
species that are likely to contribute to defective cardiac re-
polarization and conduction in progeria. Future studies are war-
ranted to establish direct causal connections between the presence
of unprocessed prelamin A or progerin and the cardiac abnor-
malities associated with HGPS, with the goal of identifying novel
targets for therapeutic intervention. Based on our findings, major
efforts should be placed into elucidating the mechanisms causing
Cx43 mislocalization in the heart of progeroid mice and HGPS
patients. These studies may pave the way to developing efficient
therapies to improve cardiac conduction in progeria.
Although ion channels are highly conserved between humans
and mice, significant electrophysiological differences exist (35),
making it difficult to translate mouse findings to the clinical
arena. For example, although we observed a tendency toward a
slower heart rate in older HGPS patients with longer follow-up,
HGPS patients did not show the bradycardia and other con-
duction abnormalities that appeared progressively in Zmpste24−/−
mice. This difference might be due to the lack of sequential ECG
assessment in humans until very advanced disease stages. Indeed,
human left ventricle specimens obtained by autopsy revealed re-
duced localization of Cx43 at gap junctions, consistent with altered
ventricular conduction velocity.
Continuous telemetry and other invasive electrophysiological
measurements would have been desirable in Zmpste24−/− mice.
However, these animals show severe body weight loss (body weight
of ∼9 g at late stages compared with ∼30 g in age-matched WT
controls) and are physically extremely fragile, precluding the use of
commercially available telemetry systems or any other invasive
approaches to register specific arrhythmias forecasting premature
death. The physical deterioration of HGPS patients also limits
implementation of any invasive measurements (e.g., implant-
able loop recordings) to further study rhythm abnormalities.
Materials and Methods
Clinical information from childrenwith HGPSwas obtained from The Progeria
Research Foundation Medical and Research Database (principal investigator
L.B.G.) and approved by the Rhode Island Hospital and Brown University
Institutional Review Boards (Providence, RI). All participants or parents
provided written informed consent in the primary language of the partici-
pant or parent. When appropriate, interpreters were used for consenting. At
least one ECG recorded no more than 3 y before death was obtained from
each of 15 HGPS patients. Thirteen gender- and age-matched control vol-
unteers were weighed, and ECG traces were recorded for comparison. All
control volunteers or parents provided written informed consent. Animal
studies were carried out in male Zmpste24−/−mice (11) and age-matched WT
male littermates (all C57BL/6). Mice were reared and housed in accordance
with institutional guidelines and regulations and all procedures with mice
were approved by the Centro Nacional de Investigaciones Cardiovasculares
Carlos III (CNIC) Ethical Committee. All other detailed materials and methods
are described in SI Appendix, SI Materials and Methods.
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